Diabetes & Mental Health in Integrated Settings: Depression and Anxiety

1. Increased insulin resistance causes changes in the hypothalamic pituitary axis, which can lead to depression and anxiety.

a) True
b) False

2. The PHQ-9 is the validated screening tool to screen for depression in patients with diabetes.

a) True
b) False

3. The Generalized Anxiety Disorder (GAD) is a 7-item scale used to screen for anxiety.

a) True
b) False

4. Treatment for depression and anxiety include:

a) Medications such as SSRIs, SNRIs, bupropion
b) Therapy such as cognitive behavioral therapy or behavioral activation
c) Stress management
d) Address social determinants of heath
e) All of the above

5. Altered function of the hypothalamic-pituitary-adrenal (HPA) axis in people with Type 2 diabetes has been show to increase the risk of depression as well as cause downstream effects resulting in upregulation of gluconeogenesis and dyslipidemia.

a) True
b) False

6. Behavioral Health Providers can help manage people with diabetes by:

a) Helping the patient set realistic goals
b) Identify barriers and solutions
c) Provide individual and group support
d) Help improve communication with their medical provider
e) All of the above

7. Motivation interviewing allows for patient engagement and has shown improvement in patient outcomes.

a) True
b) False

8. The following is/are examples of interventions that behavioral health consultants can execute during an appointment with a person with diabetes:

a) Assess social determinants of health, emotional health and social support
b) Advise on stress management and links between depression and diabetes
c) Assist with behavioral or lifestyle changes
d) All of the above

9. A score greater than or equal to 10 indicates a possible diagnosis of anxiety when using the GAD-7 scale.

a) True
b) False